Online Investing Reports
  • Investing
  • Stock
  • World News
  • Tech News
  • Editor’s Pick
Editor's PickInvesting

Government-funded Research Published in Government-funded Journals—What Could Go Wrong?

by May 28, 2025
May 28, 2025

Jeffrey A. Singer

science research

Secretary of Health and Human Services (HHS) Robert F. Kennedy, Jr., told listeners on the “Ultimate Human” podcast yesterday that he might prevent government researchers from publishing their findings in the prestigious medical journals, according to the Washington Post.

Kennedy singled out The Lancet, the New England Journal of Medicine, and JAMA (the Journal of the American Medical Association), labeling them corrupt and “under the control of the pharmaceutical industry.” He expressed his desire for the Department of HHS to establish its own journals and stated that the government would require researchers it funds to publish their findings exclusively in those journals. On the podcast, Kennedy noted that these journals will, by definition, be preeminent, “because if you get [NIH] funding, it is anointing you as a good, legitimate scientist.”

Let’s set aside the question of whether independent and prestigious medical journals are susceptible to the influence of pharmaceutical companies. What can we expect to occur when political appointees (e.g., the directors of the National Institutes of Health and the Food and Drug Administration) decide how to allocate taxpayer money for research aimed at advancing the government’s scientific agenda, which will subsequently be peer-reviewed and published in government journals?

The saying goes, “Whoever funds the music sets the melody.” In his farewell address, President Dwight Eisenhower cautioned against the risk that public policy might fall under the sway of a powerful, scientific-technological elite. Scientists applying for grants often avoid challenging dominant views, knowing such dissent could hurt their chances of funding. As outlined here and here, government-backed funding can distort the integrity of scientific inquiry.

Privately funded researchers compete in the marketplace of ideas, seeking to publish their findings in competing private sector journals. While no individual is immune to corrupting forces, a competitive and open scientific public square is more likely to arrive at the truth and progress than a government monopoly, which is inescapably vulnerable to political and special interest concerns.

If Secretary Kennedy is serious about reforming science, he should focus on fostering independence and transparency, not on consolidating control. Creating government-run journals that publish only government-funded research reviewed by government-appointed editors risks transforming science into propaganda. 

The best safeguard for scientific integrity isn’t more centralization—it’s competition, open debate, and the freedom to follow the evidence wherever it may lead.

previous post
Why Ending the War in Ukraine Is So Difficult Now
next post
Top Sectors to Watch + The 18 SMA Setup Every Trader Should Know

Related Posts

S&P 500 on the Verge of 6,000: What’s...

June 4, 2025

Why ADX Can Mislead You — And How...

June 4, 2025

Strategic Chaos or Tactical Goldmine? What QQQ’s Chart...

June 4, 2025

Meet the New Steel Tariffs, Same as the...

June 4, 2025

From Nutrition to Nannying: Texas SB 25 and...

June 4, 2025

S&P 500 Bullish Patterns: Are Higher Highs Ahead?

June 3, 2025

Local Government Corruption: 15 Case Studies

June 3, 2025

How I Find Up-trending Stocks Every Week (Step-by-Step...

June 3, 2025

The FTC Event that Wasn’t: The Attention Economy...

June 3, 2025

Grace-Marie Turner, RIP

June 3, 2025

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • 1

      S&P 500 on the Verge of 6,000: What’s at Stake?

      June 4, 2025
    • 2

      Why ADX Can Mislead You — And How to Avoid It

      June 4, 2025
    • 3

      Strategic Chaos or Tactical Goldmine? What QQQ’s Chart is Whispering Right Now

      June 4, 2025
    • 4

      Meet the New Steel Tariffs, Same as the Old Steel Tariffs

      June 4, 2025
    • 5

      From Nutrition to Nannying: Texas SB 25 and the New Public Health Overreach

      June 4, 2025
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 OnlineInvestingReports.com All Rights Reserved.

    Online Investing Reports
    • Investing
    • Stock
    • World News
    • Tech News
    • Editor’s Pick